Page last updated: 2024-09-05

solifenacin succinate and Acute Bacterial Prostatitis

solifenacin succinate has been researched along with Acute Bacterial Prostatitis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
He, Y; Jiang, J; Shen, C; Wang, W; Yang, B; Yu, Y1
Kagan, OF; Kheĭfets, VKh; Sosnovskiĭ, SO1

Trials

1 trial(s) available for solifenacin succinate and Acute Bacterial Prostatitis

ArticleYear
[Peculiarities of clinical course, diagnostics and treatment of overactive bladder in men older than 60 years].
    Advances in gerontology = Uspekhi gerontologii, 2014, Volume: 27, Issue:3

    Topics: Aged; Aged, 80 and over; Drug Therapy, Combination; Humans; Male; Middle Aged; Prazosin; Prostatic Hyperplasia; Prostatitis; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder, Overactive; Urodynamics; Urological Agents

2014

Other Studies

1 other study(ies) available for solifenacin succinate and Acute Bacterial Prostatitis

ArticleYear
Resveratrol improves urinary dysfunction in rats with chronic prostatitis and suppresses the activity of the stem cell factor/c-Kit signaling pathway.
    Molecular medicine reports, 2017, Volume: 16, Issue:2

    Topics: Animals; Chronic Disease; Diphtheria-Tetanus-Pertussis Vaccine; Disease Models, Animal; Down-Regulation; Male; Phosphatidylinositol 3-Kinases; Phosphorylation; Prostate; Prostatitis; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-kit; Rats; Rats, Sprague-Dawley; Resveratrol; Signal Transduction; Solifenacin Succinate; Stem Cell Factor; Stilbenes; Urinary Bladder

2017